To our knowledge, there are several knowledge gaps that would benefit from additional clinical trials researching the impact of cannabis on cancer treatment, including the impact of cannabis on the treatment of oncogenic mutations (e.g., HRAS, KRAS, NRAS, BRAF, and EGFR). This evidence concerns the gene HRAS and cancer.